Grifols SA (GIKLY) stock
GIKLYOTCPharmaceutical PreparationsAlso trades as GIFLF, GIFOF, GRFS
$5.55+0.00 (0.00%)
Close on Oct 19, 2026Market cap $1.91BP/E 4.2Yield –
Grifols operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
For fiscal 2025 it was €1.24B, up 4.3% from the year before. Over ten years it grew 2.5% a year on average. The highest annual figure on record is €1.24B in fiscal 2025.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | €1.24B | +4.3% |
| FY2024 | Dec 31, 2024 | €1.19B | +52.4% |
| FY2023 | Dec 31, 2023 | €782.00M | -0.1% |
| FY2022 | Dec 31, 2022 | €782.44M | +31.5% |
| FY2021 | Dec 31, 2021 | €595.06M | -40.3% |
| FY2020 | Dec 31, 2020 | €996.13M | -12.0% |
| FY2019 | Dec 31, 2019 | €1.13B | +13.8% |
| FY2018 | Dec 31, 2018 | €994.12M | -0.9% |
| FY2017 | Dec 31, 2017 | €1.00B | +6.8% |
| FY2016 | Dec 31, 2016 | €939.41M | -3.2% |
| FY2015 | Dec 31, 2015 | €970.37M | – |
See a number that looks wrong?